TC
Alaunos Therapeutics, Inc.
TCRT · NASDAQ
$1.51 -1.95% (-$0.03)
1M -21.76%
Market Cap $3.81M
P/E Ratio -
Div. Yield -
ROE 232.60%
Piotroski F-Score Weak
1/9Valuation
14 /100
Expensive P/S 1,269.59x
P/B 5.84x
P/E N/A
Growth
0 /100
Declining Rev. growth 88.04%
Book val. growth 61.78%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 27,833.30%
Net margin 133,667.00%
FCF margin 94,166.60%
Quality
0 /100
Poor ROIC 622.39%
ROE 232.60%
Asset turnover 0.00x
Debt
74 /100
Low Debt/Equity 0.00x
Current ratio 0.77x
Int. coverage N/A
Stability
29 /100
Unstable Beta -0.97x
Rev. volatility 104.01%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TCRT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Holger Weis
Employees
1
Headquarters
Fort Lauderdale
Upcoming events
17 NOV
Earnings
Upcoming earnings report